Ten new 1, 5-diarylpyrazole-3-carboxamide compounds were synthesized and their structures were identified by 1H-NMR and FAB-MS. The primary biological tests showed that compound 4j exhibited some ALK5 inhibitory activ...Ten new 1, 5-diarylpyrazole-3-carboxamide compounds were synthesized and their structures were identified by 1H-NMR and FAB-MS. The primary biological tests showed that compound 4j exhibited some ALK5 inhibitory activity at concentration of 1μmol/L.展开更多
The asymmetric synthesis of (-)-(4R, 5R)-4-[5-(benzo[1, 3]dioxol-5-yl)-4-hydroxyl-1- (pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl]-benzamide with improved Juliá-Colonna asymmetric epoxidation procedure as key step ...The asymmetric synthesis of (-)-(4R, 5R)-4-[5-(benzo[1, 3]dioxol-5-yl)-4-hydroxyl-1- (pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl]-benzamide with improved Juliá-Colonna asymmetric epoxidation procedure as key step was described.展开更多
文摘Ten new 1, 5-diarylpyrazole-3-carboxamide compounds were synthesized and their structures were identified by 1H-NMR and FAB-MS. The primary biological tests showed that compound 4j exhibited some ALK5 inhibitory activity at concentration of 1μmol/L.
基金This work was supported by Chinese National Basic Developing Project(973 project:2004CB518908).
文摘The asymmetric synthesis of (-)-(4R, 5R)-4-[5-(benzo[1, 3]dioxol-5-yl)-4-hydroxyl-1- (pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl]-benzamide with improved Juliá-Colonna asymmetric epoxidation procedure as key step was described.